Nordic Bioscience Overview
- Year Founded
-
1991
- Status
-
Acquired/Merged
- Employees
-
212
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
3
- Investments
-
3
Nordic Bioscience General Information
Description
Developer of novel biomarkers dedicated to enhancing the drug development process. The company offers measurement of specific neo-epitopes and specializes in the mode of active investigation and efficacy assessment in the fields of hepatic diseases, respiratory, renal, cardiovascular and other related areas, enabling its clients to diagnose and prognosis various diseases.
Contact Information
Website
www.nordicbioscience.com(Operating Subsidiary)
Corporate Office
- Herlev Hovedgade 205
- 2730 Herlev
- Denmark
Corporate Office
- Herlev Hovedgade 205
- 2730 Herlev
- Denmark
Nordic Bioscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nordic Bioscience Comparisons
Industry
Financing
Details
Nordic Bioscience Competitors (12)
One of Nordic Bioscience’s 12 competitors is Genewiz, a Formerly VC-backed company based in South Plainfield, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genewiz | Formerly VC-backed | South Plainfield, NJ | ||||
| Sphere Fluidics | Formerly VC-backed | Cambridge, United Kingdom | ||||
| NGM Biopharmaceuticals | Private Equity-Backed | South San Francisco, CA | ||||
| CTI Clinical Trial and Consulting | Private Equity-Backed | Covington, KY | ||||
| Actym Therapeutics | Venture Capital-Backed | Berkeley, CA |
Nordic Bioscience Patents
Nordic Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202504386-D0 | A-synuclein assay | Pending | 26-Mar-2025 | ||
| WO-2026202211-A1 | Alpha-synuclein assay | Pending | 26-Mar-2025 | ||
| GB-202415024-D0 | Endotrophin assay | Inactive | 11-Oct-2024 | ||
| GB-202413581-D0 | Immunoassay for detecting collagen i fragment | Inactive | 16-Sep-2024 | ||
| WO-2026057848-A2 | Immunoassay for detecting collagen i fragment | Pending | 16-Sep-2024 | C07K16/18 |
Nordic Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nordic Bioscience Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nordic Bioscience Investments (3)
Nordic Bioscience’s most recent deal was a Later Stage VC with Symic Bio for . The deal was made on 22-May-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Symic Bio | 22-May-2017 | Later Stage VC | Drug Discovery | ||
| Radius Health | 16-Dec-2011 | Later Stage VC | Pharmaceuticals | ||
| SYNARC | 10-Mar-2009 | Later Stage VC | Other Healthcare Services |
Nordic Bioscience Exits (2)
Nordic Bioscience’s most recent exit was on 16-Dec-2011 from Radius Health. The exit was categorized as with 10 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Radius Health | 16-Dec-2011 | Completed |
|
||
| SYNARC | 10-Mar-2009 | Later Stage VC | Completed |
Nordic Bioscience FAQs
-
When was Nordic Bioscience founded?
Nordic Bioscience was founded in 1991.
-
Where is Nordic Bioscience headquartered?
Nordic Bioscience is headquartered in Herlev, Denmark.
-
What is the size of Nordic Bioscience?
Nordic Bioscience has 212 total employees.
-
What industry is Nordic Bioscience in?
Nordic Bioscience’s primary industry is Biotechnology.
-
Is Nordic Bioscience a private or public company?
Nordic Bioscience is a Private company.
-
What is Nordic Bioscience’s current revenue?
The current revenue for Nordic Bioscience is .
-
How much funding has Nordic Bioscience raised over time?
Nordic Bioscience has raised $100M.
-
Who are Nordic Bioscience’s investors?
Kohlberg Kravis Roberts has invested in Nordic Bioscience.
-
Who are Nordic Bioscience’s competitors?
Genewiz, Sphere Fluidics, NGM Biopharmaceuticals, CTI Clinical Trial and Consulting, and Actym Therapeutics are some of the 12 competitors of Nordic Bioscience.
-
When was Nordic Bioscience acquired?
Nordic Bioscience was acquired on 03-Sep-2026.
-
Who acquired Nordic Bioscience?
Nordic Bioscience was acquired by Immunodiagnostic Systems Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
